Business

PDMR Dealing - Replacement

PDMR Dealing - Replacement.

articleOxford Biodynamics PlcApril 2, 20204/company/oxford-biodynamics-plc/news/pdmr-dealing-replacement-1
PDMR Dealing - Replacement

About this update from Oxford Biodynamics Plc

[{"type":"text","content":"\n \n \n RNS Number : 5768I\n Oxford BioDynamics PLC\n 02 April 2020\n  \n \n \n 2 April 2020\n  \n \n Oxford BioDynamics Plc\n \n \n \n (\n \n \"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \n \n  \n \n \n Correction - PDMR Dealing\n \n  \n  \n The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 23 March 2020 at 15.21 under RNS No 2553H.\n  \n Vulpes Testudo Fund, which is controlled by Non-Executive Director, Stephen Diggle, purchased a further 26,000 Ordinary Shares of 1 pence each at a price of 51.8p per share on 19 March 2020.\n  \n Through the holdings of Vulpes Life Sciences Fund and Vulpes Testudo Fund, Stephen Diggle is interested in 12,061,670 Ordinary Shares, representing approximately 13.03% of the Company's current issued share capital.\n  \n All other details remain unchanged. The full amended text is shown below.\n  \n 23 March 2020\n  \n \n Oxford BioDynamics Plc\n \n \n \n (\n \n \"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \n \n  \n \n \n PDMR Dealing\n \n  \n \n Oxford BioDynamics Plc (AIM: OBD) \n announces that it has today received notice that Vulpes Testudo Fund, which is controlled by Non-Executive Director, Stephen Diggle, has purchased 26,000 Ordinary Shares of 1 pence each (\"shares\") at a price of 51.8p per share on 19 March 2020 and a further 15,000 shares at a price of 56.0p per share on 20 March 2020.\n \n \n  \n \n \n Following these transactions, Vulpes Testudo Fund \n is interested in 251,000 Ordinary Shares, representing 0.27% of the Company's current issued share capital. Through the holdings of Vulpes Life Sciences Fund and Vulpes Testudo Fund, Stephen Diggle is interested in 12,061,670 shares, representing approximately 13.03% of the Company's current issued share capital.\n  \n \n The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details:\n \n  \n \n \n \n \n 1\n \n \n Details of the person discharging managerial responsibilities/person closely associated\n \n \n \n \n a)\n \n \n Name\n \n \n Stephen Diggle\n \n \n \n \n 2\n \n \n Reason for the notification\n \n \n \n \n a)\n \n \n Position/status \n \n \n Director/PDMR...

More updates from Oxford Biodynamics Plc